Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Equity ETF median (66 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 17 Jul 2026 – 20 Aug 2026, limited by Mirae Asset BSE Midcap 150 Momentum 30 ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset BSE Midcap 150 Momentum 30 ETF | Nifty Midcap 150 |
|---|---|---|
| 17 Jul 2026 | ₹100.00 | ₹100.00 |
| 20 Jul 2026 | ₹100.30 | ₹100.51 |
| 23 Jul 2026 | ₹98.79 | ₹98.86 |
| 26 Jul 2026 | ₹98.61 | ₹98.77 |
| 28 Jul 2026 | ₹99.54 | ₹99.84 |
| 31 Jul 2026 | ₹101.04 | ₹100.74 |
| 03 Aug 2026 | ₹101.45 | ₹101.96 |
| 06 Aug 2026 | ₹103.38 | ₹101.49 |
| 09 Aug 2026 | ₹103.54 | ₹101.72 |
| 12 Aug 2026 | ₹104.70 | ₹102.41 |
| 14 Aug 2026 | ₹104.18 | ₹101.97 |
| 17 Aug 2026 | ₹104.59 | ₹102.12 |
| 20 Aug 2026 | ₹104.01 | ₹101.83 |
| Metric | Mirae Asset NAV ₹13.02 Very High risk Unrated | Category median Equity ETF · 66 funds |
|---|---|---|
| — | +3.95% | |
| — | +11.55% | |
| — | +10.41% | |
| — | +11.81% | |
| +4.01% | +8.19% | |
| +53.33% | — | |
| — | +13.71% | |
| — | +14.22% | |
| — | +12.98% | |
| Risk | ||
| — | 17.16% | |
| — | 0.22 | |
| — | 0.32 | |
| -1.99% | -20.98% | |
| Nifty Midcap 150 | — | |
| — | +0.65% | |
| — | 1.00 | |
| — | 101.0% | |
| — | 97.0% | |
| 5.91% | 0.37% | |
| ₹43.69Cr | ₹91.02Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| 17 Jul 2026 | — | |
| 30 | — | |
| 49.3% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.